| Terra Marisa Bufkin, LCSW-C | |
|
4626 Smokey Wreath Way, Ellicott City, MD 21042-5944 | |
| (240) 565-7544 | |
| Not Available |
| Full Name | Terra Marisa Bufkin |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4626 Smokey Wreath Way, Ellicott City, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497065130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 14279 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Terra Marisa Bufkin, LCSW-C 4626 Smokey Wreath Way, Ellicott City, MD 21042-5944 Ph: (240) 565-7544 | Terra Marisa Bufkin, LCSW-C 4626 Smokey Wreath Way, Ellicott City, MD 21042-5944 Ph: (240) 565-7544 |
News Archive
A promising new clinical study published on the preprint server medRxiv reports that if convalescent plasma with a high titer of antibodies is given early in the course of COVID-19 in elderly patients, the risk of severe illness is reduced by 73%.
New research led by Costas D. Maranas from The Pennsylvania State University predicts amino acid changes to the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein would negatively impact binding affinity and subsequent infection into human cells.
"Come and get it!" A phrase historically proclaiming that the communal meal is ready, is heard all too infrequently among contemporary American households, especially as children get older.
Intellipharmaceutics International Inc., today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for approval to market a generic of the 30 mg strength of Focalin XR® (dexmethylphenidate hydrochloride). The application for the 30 mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20 mg strengths of the drug.
Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.
› Verified 5 days ago
Liam Montanarelli, PHD, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3355 Saint Johns Ln Ste J, Ellicott City, MD 21042 Phone: 410-949-1238 | |
Mr. Charles John Semich, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8175 Baltimore National Pike, Ellicott City, MD 21043 Phone: 410-313-8804 Fax: 443-638-0204 | |
Atin Kumar, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8181 Main St Apt 2, Ellicott City, MD 21043 Phone: 757-651-3001 | |
Dr. Robert Rabinowitz, PHD, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4801 Dorsey Hall Dr Ste 200, Ellicott City, MD 21042 Phone: 410-715-1180 Fax: 410-715-1182 | |
Mrs. Dinah M. Jones, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8878 Town And Country Blvd, Suite A, Ellicott City, MD 21043 Phone: 410-465-0243 | |
Sykia Edwards, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3211 Corporate Ct # 6a, Ellicott City, MD 21042 Phone: 410-297-0932 | |
Gladys Rhem-kenney, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8181 Main St, Ellicott City, MD 21043 Phone: 757-651-3001 |